Company: LRHC
Filing Date: 2025-08-20
Form Type: S-1/A
Source: 0001213900-25-078966
Chunk: 28

Company: La Rosa Holdings Corp.
Filing Date: 2025-08-20
Form: S-1/A
Chunk 28
---
 the number of shares representing 19.99% of the issued and outstanding shares of common
stock as of the date of the Facility (the “Exchange Cap”), unless the Company has obtained stockholder approval as required
for issuance of common stock in excess of the Exchange Cap, in accordance with applicable rules of Nasdaq. Accordingly, the Company may
not have access to the right to sell the full Commitment Amount (as defined below) to the Selling Stockholder. As of August 18, 2025,
there were 1,223,918 shares of common stock outstanding, and therefore the Exchange Cap is 244,783 shares of common stock.
the Selling Stockholder will not be required to subscribe for any shares of common stock under the Facility which, when aggregated with
all other shares of common stock then beneficially owned by the Selling Stockholder and its affiliates (as calculated pursuant to Section
13(d) of the Exchange Act, and Rule 13d-3 promulgated thereunder), would result in the beneficial ownership by the Selling Stockholder
and its affiliates to exceed 4.99% (which the Selling Stockholder, upon notice to the Company, may increase or decrease but in no event
in excess of 9.99%) of the outstanding voting power or number of the common stock.

If, following satisfaction of the conditions set
forth in the Facility, we elect to sell to the Selling Stockholder all of Shares being registered for resale hereunder, depending on the market prices of
our common stock at the time of such sales, the gross proceeds from such sales of all such shares of common stock by us to the Selling Stockholder may be
substantially less than the $150,000,000 total purchase commitment available to us under the Facility, which could materially adversely
affect our liquidity.

If it becomes necessary for us to issue and sell
to the Selling Stockholder shares of common stock in excess of the Exchange Cap under the Facility in order to receive additional gross proceeds up to $150,000,000
under the Facility, then for so long as the Exchange Cap continues to apply to the issuances and sales of our common stock under the Facility,
we must first obtain stockholder approval to issue shares of common stock in excess of the Exchange Cap in accordance with the applicable
Nasdaq listing rules. Any issuance and sale by us under the Facility of shares of common stock in excess of the Exchange Cap could cause
additional substantial dilution to our stockholders. The